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Introduction
When planning an individual case for anaesthesia, we have the choice between various well-established, tested methods and drugs. Contraindications might prohibit the use of certain drugs in special cases, while usually an alternative of the same category might be suitable. Examples of such absolute contraindications are trigger 
substances in patients susceptible for malignant hyperthermia or barbiturates in patients with hepatic porphyria. However, 
in a vast majority of cases, there is ample room for choosing a drug vs its alternatives of the same category. It is interesting 
to know what causes the decision in favour of a certain drug vs its established alternatives.
Drugs of the same category may have certain differences in their pharmacokinetic and pharmacodynamic properties (1-3), 
which in turn may influence the choice for a certain drug against the available alternatives, albeit the medical indications 
may largely overlap. However, there are many other reasons in favour of certain drug, such as local tradition, economic 
reasons, logistic circumstances or simply personal preference of the person who plans the upcoming anaesthesia (2, 4-7). 
From this large spectrum of possible decisions, we distinguish choices for a certain drug that are based on locally accepted 
standards vs unfounded alternatives, which however may be still acceptable from a strict medical point of view.
To illuminate this still rather obscure field of drug-related decision-making, we decided to interview attending anaesthetists 
from our anaesthesia department on their individual choices based on the existing cases scheduled for the following day, 
while carefully avoiding a biasing effect due to the interview itself. We categorised the decisions as justified or unjustified 
according to accepted pharmacological knowledge and logistic conditions in our department.
Objective: Various drugs are available for general anaesthesia, and the anaesthesiologist in charge may choose the one that is considered as 
the most appropriate for each specific case. When selecting an anaesthetic drug, its specific pharmacokinetic and pharmacodynamics as well 
as certain non-pharmacological properties have to be considered. This may lead to decisions that may be justified or unjustified according to 
scientific evidence and local standards.
Methods: In a prospective, single-centre, non-randomised and non-interventional study, 30 attending anaesthetists were interviewed 
about their drug prescription for general anaesthesia cases scheduled for the next day. The stated reasons for their choices from available 
alternatives were recorded and analysed for being justified or unjustified.
Results: We found 69% of all decisions as justified, while 31% were incorrect, unjustified or random. Female anaesthetists made 
83%±15% justified decisions, whereas males achieved a lower performance with 69%±17% justified decisions (p=0.046).
Conclusion: To a large proportion, convenience, habit and personal preferences influence the decision-making in choosing the anaesthet-
ic medication. A change of paradigm in the postgraduate education and training seems to be necessary.
Keywords: Anaesthetic drugs, decision making, practice standards, postgraduate education.
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Methods
In this prospective, approved (Cantonal Ethics Committee, 
KEK-ZH 2015-0539, chaired by Peter Meier-Abt, issued on 
18.8.2016), single-centre, non-randomised study, we inter-
viewed all senior anaesthetists from the anaesthesia depart-
ment, which belongs to a tertiary, academic hospital, after 
they concluded the planning for the following days’ elective 
cases. These were 30 board-certified attending anaesthesiol-
ogists who provided written consent to be interviewed on 
cases they have individually dealt with. They were addressed 
face-to-face while viewing their finalised prescription for the 
discussed cases of the following day. The personal interview 
was not declared in advance to not influence the subjects’ 
anaesthetic decisions by the questions. Their previous deci-
sions for or against anaesthetic drugs for adult patients (aged 
>18 years) undergoing elective general anaesthesia were doc-
umented, as well as the stated reasons for their decisions. One 
interviewee dropped out. Each interview lasted approximate-
ly 15 min. Data saturation was not an issue, as the study in-
volved 30 board-certified attending anaesthesiologists of the 
university hospital. The researcher’s interest in the topic was 
communicated.
The standardised questionnaire comprised of questions relat-
ed to four pairs of commonly prescribed anaesthesia drugs 
of the same category, which could be chosen alternatively. 
Each case could comprise multiple decision pairs. The stated 
reasons for their choices by the interviewed senior anaesthe-
tists were assessed after their decision-making and compared 
with a standardised list of justified and unjustified reasons 
(Table 1).
The reasons for choosing one of the two alternatives from 
each pair of alternative drugs, as indicated by the investi-
gated anaesthesiologists, comprised pharmacokinetic and 
pharmacodynamic considerations, as well as miscellaneous 
non-pharmacological reasons such as availability, costs, local 
tradition and personal habit.
At this point, we must emphasize that with ‘unjustified’ drug 
choices we do not mean a medical risk for the involved pa-
tients. The decisions labelled as ‘unjustified’ indicate certain 
non-vital disadvantages for the operating unit, e.g. longer 
duration for emergence from anaesthesia (by choosing a drug 
with a less favourable pharmacokinetic profile). Choosing a 
drug with a less favourable pharmacodynamic profile would 
eventually cause less haemodynamic stability and the neces-
sity of corrective measures. Finally, if a drug choice was un-
favourable for non-pharmacological (e.g. logistic) reasons, it 
might delayed the operating room schedule. The qualitative 
aspects of this study were assured by using the consolidated 
criteria for reporting qualitative research checklist (8).
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Table 1. Main justified arguments for favouring an anaesthetic drug against its alternative that were used for the assessment of the 
anaesthetists’ answers during the interview
Drug choice Justified arguments
Induction i.v.-hypnotics (propofol vs 
thiopental)
Favouring propofol PONV  history
Favouring thiopental Rapid sequence induction, polytoxicomania
Volatile anaesthetics for maintenance 
(sevoflurane vs desflurane)
Favouring sevoflurane Obstructive pneumopathy, laryngeal mask
Favouring desflurane Renal disorder, obesity
Neuromuscular blocking drugs (rocu-
ronium vs atracurium)
Favouring atracurium Renal disorder
Favouring rocuronium
Permanent blockade necessary and reversal 
with sugammadex planned
Opioid strategy for maintenance (fen-
tanyl alone vs fentanyl/ remifentanil 
combination)
Favouring fentanyl alone Postoperative prolongation of analgesia required
Favouring a fentanyl/remifentanil 
combination
Rapid transition to spontaneous ventilation required
PONV: postoperative nausea and vomiting.
Table 2. Overview of all drug choices by category. Number of 
choices (percentage inside the respective drug pairs)
Drug pairs (n) Drug choice
Decisions 
n (%)
Justified 
decisions 
(%)
Propofol vs 
thiopental (30)
Favouring 
propofol 27 (90) 66
Favouring 
thiopental 3 (10)
Sevoflurane vs 
desflurane (14)
Favouring 
sevoflurane 12 (86) 71
Favouring 
desflurane 2 (14)
Rocuronium vs 
atracurium (25)
Favouring 
atracurium 19 (73) 55
Favouring 
rocuronium 7 (27)
Fentanyl alone 
vs fentanyl/ 
remifentanil 
combination 
(30)
Favouring 
fentanyl alone 9 (30) 86
Favouring a 
fentanyl/
remifentanil 
combination
21 (70)
All pairs All choices 99 69
Biometric and clinical details of the patients in the investi-
gated cases were recorded to evaluate the appropriateness of 
pharmacological decisions. Age, gender and amount of pro-
fessional experience (in years of activity) of the interviewed 
subjects were also documented. 
Data were transferred into an Excel (Microsoft, Seattle) 
spreadsheet, which was also used for computing the descrip-
tive statistics. Further calculations, statistical analyses and il-
lustrations were performed in GraphPad Prism 6.0 (Graph 
Pad Incorporation, La Jolla, CA). Unless otherwise stated, 
data are presented as mean [±standard deviation (SD)]. Each 
subject’s quality level for their decisions was displayed as the 
ratio of justified/unjustified decisions. A linear regression was 
made between the ratio of the justified/unjustified decisions 
on one hand and the duration of professional experience on 
the other. The percentage of justified decisions of male vs 
female participants and the number of decisions taken that 
passed the Shapiro-Wilks normality test were compared by a 
two-tailed Student’s t-test; a p value of <0.05 was considered 
statistically significant.
Results
During the investigation period, we collected data from 30 
attending anaesthetists of our department, who were in-
volved in planning elective anaesthesia cases for the next day. 
We interviewed nine females and 21 males. The average age 
was 42.3 (±7.8) years ranging from 33 to 62 years, and the 
mean duration of professional experience as specialists was 
8.4 (±7.3) years ranging from 1.5 to 28 years.
The involved anaesthetists made 99 choices from the avail-
able four drug pairs or medication alternatives (Table 2).
Overall, we found 69 justified and 30 unjustified pharmaco-
logically and logistically inappropriate decisions, respectively. 
The lowest individual level of justified/unjustified ratio was 
0.33 and the highest was 1.0 (Figure 1).
The number of justified decisions was not related to the du-
ration of professional experience (Figure 2). However, there 
was a gender difference in favour of women (Figure 3). While 
the number of decisions per anaesthesia case taken by female 
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Figure 1. Number of decisions for drug choices made by senior 
anaesthetists and ratio of justified/unjustified decisions (J/U-ra-
tio)
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Figure 2. Linear regression of justified vs unjustified decisions 
(as J/U ratio) in correlation with the professional experience in 
years. We observed no correlation between professional expe-
rience and adherence to the locally adopted standards (J/U-ra-
tio). The regression line describes almost a horizontal line with 
the equation: y=0.0057*x+73.02, R2=5.7*10-6
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Figure 3. Comparison of justified/unjustified (J/U) ratio from 
male vs female senior anaesthesiologists presented as boxplo-
ts (25%-75% percentile, whiskers represent minimum and 
maximum values). Female senior anaesthesiologists had a sig-
nificantly higher J/U-ratio indicating a closer adherence to the 
locally adopted standards compared to their male colleagues 
(*p=0.046).
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anaesthetists was similar to their male colleagues [5.1 [±2.3] 
vs 6.1 [±2.3]; p=0.29], women made 83% justified decisions, 
whereas men showed a significantly lower performance in 
this regard with 69% (p=0.046).
Discussion
The sample size of 30 investigated colleagues was determined 
by the existing size of the staff and therefore represents the 
maximally possible number of interviews.We demonstrated 
that 69% of the anaesthetic drug choice decisions made by 
experienced attending anaesthesiologists were justified and 
in accordance with the generally accepted pharmacological 
knowledge, whereas the remainder of 31% were unjustified 
(albeit not representing medical risks for the involved patients). 
The ratio of justified/unjustified choices was independent of 
the professionals’ level of experience. Only the scattering 
appears to be broader in younger health care professionals 
indicating a larger spread in pharmacological knowledge and 
its availability for application in clinical reality. Interestingly, 
female attending anaesthetists performed significantly better 
than their male peers. Determining the ratio of justified/
unjustified choices was the major theme of the study; the 
secondary objective was to determine the difference in 
performance related to gender or professional experience. 
Decisions concerning the induction of anaesthesia (propo-
fol vs thiopental) were most frequent with a large predomi-
nance favouring propofol. These choices were appropriate in 
a majority of the cases (66%) (9-11). However, the remain-
ing 34% of unjustified decisions is still worrying. Similarly, 
the neuromuscular blockers atracurium (favoured in 27%) 
vs rocuronium (favoured in 73%) were justifiably chosen in 
55% (12, 13), while in 45% the decisions happened random-
ly. The choices for volatile anaesthetics resulted in a strong-
ly asymmetric distribution favouring sevoflurane in 86% vs 
desflurane in 14%, which were justified in 71% (14-16). In 
particular, the strong preference of sevoflurane over desflu-
rane was often due to a personal habit; however, economic 
arguments favouring sevoflurane are considered justified (5, 
17-19). In the case of intraoperative opioid analgesia, there 
were in 30% decisions in the favour of fentanyl alone vs 70% 
for a combination of fentanyl/remifentanil, of which 86% 
were justified (20).
We expect that board-certified anaesthesiologists to plan 
their upcoming anaesthesia according to well-established and 
evidence-based considerations in accordance with the actual 
state of professional knowledge and appropriate medical 
care. A combination of well-founded pharmacokinetic, 
pharmacodynamic and non-pharmacological considerations 
should build the basis of such decisions. However, we 
observed that many decisions were based on personal habit, 
scientifically not substantiated preferences and ignorance or 
wrong information about the prevailing conditions of the 
patient and planned surgery. Most probably, unjustified 
choices may even have occurred randomly, as mentioned by 
other authors (1, 3, 21, 22). Fortunately, modern commonly 
used drugs in anaesthesia are very safe and have a broad range 
of indications. There are only few clear contraindications that 
are easy to be respected, and these were never contradicted by 
our staff members in the frame of this study.
An inappropriate pharmacokinetic consideration may for 
example result in a longer awakening period and reduced 
efficiency of the operation unit, which is not vital for an 
individual patient but is economically disadvantageous for the 
operative institution (23). An inappropriate pharmacodynamic 
choice may primarily affect the perioperative comfort of the 
patients and only rarely may cause morbidity, by eventually 
not preventing haemodynamic variations, as it would be 
with a more adequate drug choice (14, 22-25). Finally, 
inappropriate non-pharmacological considerations may have 
negative logistic or economic consequences (19).
A professional experience of up to 28 years had no impact on 
the appropriateness of the judgements. Remarkably, the nine 
females performed significantly better as compared to their 
21 male peers.
The overall average of 31% unjustified and partially incor-
rect, inappropriate or randomly made drug-related choices 
is problematic. This seems to be even more worrisome con-
sidering that experienced personnel are entitled to decide on 
indications on their own, without consulting a superior. Les-
lie at al. found a comparable amount of unjustified decisions 
among anaesthetists and confirmed our finding that ‘conve-
nience and habit’ are important factors in the choice of an-
aesthetics (2). Thus, it seems that there is still much room for 
pharmacological education and professional instruction, even 
in the experienced and educated subgroup of our colleagues. 
Another conclusion is that seemingly even professional ex-
pertise of several years does not improve the competence for 
scientifically sound and clinically justified decision-making.
Our investigation aimed to quantify unjustified drug choices 
for scientific and local logistic reasons, and we consider the 
percentage of 31% inappropriate decisions as noteworthy or 
even alarming from an educational point of view. Further in-
vestigation of postoperative outcome parameters due to phar-
macological decisions was not the focus of this trial. Howev-
er, even in the case of ‘unjustified’ decisions, there were no 
medical complications or lasting changes to be expected. This 
aspect should be addressed in future investigations concern-
ing clinical decision-making in anaesthesia on a broader scale.
There are a few limitations to our study. We present data 
from a single-centre with a limited number of participants, 
which was given by the size of the department. Our results 
may need to be confirmed in larger multicentre trials, but 
we are confident that our findings are comparable to oth-
er institutions and countries with similar postgraduate ed-
ucation systems. In addition, our study cannot exclude the 
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non-logical factors influencing the subject’s decision. The 
interview was conducted retrospectively to the investigated 
decision-making, but we consider the risk of a wrong recall 
as small, since the interviews were performed after the in-
terviewed colleagues have concluded their anaesthesia plans 
for the next day. An essential strength of our study is that 
we interviewed the chosen anaesthesiologists after they had 
concluded their anaesthesia planning to ensure that the data 
collection itself did not influence the results. To obtain com-
parable data, we used a structured questionnaire and concen-
trated on a small but representative selection of alternative 
drug pairs.
Conclusion
To our knowledge, this is the first systematic clinical study on 
real-world pharmacological decision-making involving expe-
rienced attending anaesthesiologists, investigating the ap-
propriateness of pharmacological and non-pharmacological 
considerations. We hope that our study will raise attention to 
this rather neglected topic and may encourage attending an-
aesthesiologists to accelerate self-education efforts. We con-
sider our results to be a proof for the necessity of continuing 
education in pharmacology for anaesthesiologists, indepen-
dent of their level of clinical experience.
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